MOFCOM, the NDRC and the Ministry of Finance issued an Action Plan to stabilise
and upgrade foreign investment, pledging support for foreign participation in
high‑quality development of the pharmaceutical sector. They will expedite
drafting implementation rules to allow overseas marketing‑authorization holders
to undertake cross‑border staged production of biologics and chemical drugs, and
will fast‑track approval to expand pilot zones for biotechnology and wholly
foreign‑owned hospitals. The plan also backs insurers including more innovative
drugs and devices in commercial coverage, encourages entry of high‑quality
innovative products into the Chinese market, and calls for an industry
cooperation platform to ease foreign‑made drugs’ access to retail distribution
channels.
